Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

FGFR3

RBC: FGFR3 · Substrate: pEY + Mn ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Pemigatinib99.40.72
Erdafitinib99.10.74
Futibatinib99.00.72
Infigratinib98.60.71
Alpelisib98.60.72
Tenalisib98.00.70
Ponatinib96.70.53
Deucravacitinib93.30.72
Axitinib93.10.69
Nintedanib91.00.61
Pralsetinib90.60.64
Selpercatinib86.60.64
Lenvatinib79.90.73
Pazopanib78.70.67
Brigatinib74.60.51

Known variants

Cancer associations

MutationCancer typeOrganSource
C491Acarcinoma_lungLunghttps://www.cancer.gov/tcga.
C491Acarcinoma_lungLunghttps://www.cancer.gov/tcga.
C491Scarcinoma_lungLunghttps://doi.org/10.1093/nar/gkaa944
G697Ccarcinoma_upper_aerodigestive_tractBrain/CNShttps://doi.org/10.1093/nar/gkaa945
G697Ccarcinoma_stomachStomach/Digestive Tracthttps://doi.org/10.1093/nar/gkaa945
K650EMyelomaBlood/Lymphatic Systemhttps://doi.org/10.1093/nar/gkaa945
K650EBladder CancerBladderhttps://doi.org/10.1093/nar/gkaa945
K650Eother_skinSkinhttps://doi.org/10.1093/nar/gkaa945
K650Ecarcinoma_urinary_tractBiliary Tracthttps://doi.org/10.1093/nar/gkaa945
K650Eglioma_central_nervous_systemBrain/CNShttps://doi.org/10.1093/nar/gkaa945
K650Elymphoid_neoplasm_haematopoietic_and_lymphoid_tissueBlood/Lymphatic Systemhttps://doi.org/10.1093/nar/gkaa945
K650Egerm_cell_tumour_testisGenitourinary systemhttps://doi.org/10.1093/nar/gkaa945
K650Ecarcinoma_breastBreasthttps://doi.org/10.1093/nar/gkaa945
K650Ecarcinoma_skinSkinhttps://doi.org/10.1093/nar/gkaa945
K650EBLCA-CNBladderhttps://doi.org/10.1093/nar/gkaa945
K650EBLCA-USBladderhttps://doi.org/10.1093/nar/gkaa945
K650EMMBlood/Lymphatic Systemhttps://doi.org/10.1093/nar/gkaa945
K650EBLCABladderhttps://doi.org/10.1093/nar/gkaa945
K650Mother_skinSkinhttps://doi.org/10.1093/nar/gkaa945
K650Mcarcinoma_urinary_tractBiliary Tracthttps://doi.org/10.1093/nar/gkaa945
Open in new tab